ARCHIVES

NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says

This article is from The Cancer Letter archive.

Vol. 20 No. 47 | December 9, 1994

Download PDF Visit The Full Archive

Related Articles

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992